Molnupiravir Market Analysis By Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Report Description

Global Molnupiravir market may register an impressive growth in the forecast period, 2023-2027, due to rising demands for the effective pharmaceuticals for the rising cases of COVID-19. High prevalence of the disease coupled with the viral variant complicating the conditions of the patients and thus leading to the severe conditions of the infection and causing death for population, drives the growth of the global Molnupiravir market in the upcoming five years. Furthermore, increasing research and development activities by various pharmaceutical & biotechnology players for the development of potential antiviral drugs is anticipated to foster the market growth.

Molnupiravir is an orally bioavailable form of a potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV2, the causative agent of COVID-19. In simpler terms, the pharmaceutical product Molnupiravir is an orally administered drug that has higher potency as compared to other antiviral drugs against COVID-19. The drug has the chemical component of mRNA that can act against the viral, and COVID infection causing virus’ RNA. This RNA sequence has effect against the new SARS-CoV2 too is thus use for the controlling the effects of COVID-19.

Rising Instances of COVID-19 Drives Market Growth

Growing instances of COVID-19 positive cases are a major factor driving the growth of the global Molnupiravir market in the upcoming five years. Although through effective vaccinations and use of precautionary steps, the rapid growth in the cases have been controlled. Although, growing variants of the virus and its evolving effect over the human body affects the lives, and thus the demands for the efficient pharmaceuticals such as Molnupiravir increases thereby supporting the growth of the global Molnupiravir market in the next five years.

As of 24^th May 2022, there are already 528.37 million CVID-19 cases around the world, out of which 85.11 million cases belong from the United States itself. With the viral infection affecting such a large population in the country, the United States’ government had hastily authorized the administration of Molnupiravir to the patients suffering from the mild symptoms of COVID-19. The orally administered capsules had certain concerns and side-effects in its early phase outs. Soon followed by the affordability of the drug as compared to other available treatment drugs, the industry for the drug expanded and with Clinical Phase III human trials already approved, the drug is expected to substantially grow in the forecast years.

Investments & Advancement Wheel In Further Market Growth

Rising investment in the pharmaceutical industry and growing expenses from the consumers toward effective drug development and overcoming the disease, drives the growth of the global Molnupiravir market in the upcoming five years. The consumers are eager to adapt to the more advanced, highly effective, and efficient drugs. If these drugs are affordable and are available in the local pharmaceutical markets, the distribution channel efficiency further fuels the growth of the global Molnupiravir market in the next five years.

In 2021, more than 3 million courses of Molnupiravir were supplied to the U.S. government within approximately 7 weeks of receiving emergency use authorization from the U.S. food and drug administration. The demands for the drugs are high in the North American region looking at the growing instances of the cases in the country. Further evolutions in other pharmaceuticals and advancement in the innovative COVID-19 restricting drugs may create restraint on the growth of the market.

Click here to download the sample

Market Segmentation

The global Molnupiravir market segmentation is based on application, distribution channel, regional distribution, and competitive landscape. Based on application, the market is fragmented into influenza, Ebola, COVID-19, and others. By distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Merck Sharp & Dohme Corp., Everest Organics Limited, Optimus Drugs Pvt Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Mylan N.V., Emcure Pharmaceuticals Ltd., Sun Pharmaceutical Industries Limited, Hetero Drugs Ltd., Torrent Pharmaceuticals Ltd., are enlisted in a partial list of major market players of the global Molnupiravir market.

Attribute	Details
Base Year	2021
Historical Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· Application · Distribution Channel
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States, Mexico, Canada, China, India, Japan, Australia, South Korea, Vietnam, Philippines, Indonesia, Malaysia, Germany, France, United Kingdom, Spain, Italy, Denmark, Brazil, Argentina, Colombia, South Africa, UAE, Saudi Arabia, Kenya.
Key companies profiled	Merck Sharp & Dohme Corp., Everest Organics Limited, Optimus Drugs Pvt Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Mylan N.V., Emcure Pharmaceuticals Ltd., Sun Pharmaceutical Industries Limited, Hetero Drugs Ltd., Torrent Pharmaceuticals Ltd.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global Molnupiravir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Molnupiravir Market, By Type:

Influenza
Ebola
COVID-19
Others

Molnupiravir Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Molnupiravir Market, By Region:

North America

United States
Mexico
Canada

Asia-Pacific

China
India
Japan
South Korea
Australia
Vietnam
Philippines
Indonesia
Malaysia

Europe

France
Germany
United Kingdom
Spain
Italy
Denmark

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE
Kenya

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Molnupiravir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Molnupiravir Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Molnupiravir Market

4. Executive Summary

5. Voice of Customer

5.1. Factors Contributing to Demand of Molnupiravir

5.2. Choice of Source for Procuring Molnupiravir

5.3. Source of Information

5.4. Barriers to Adoption of Molnupiravir

5.5. Brand Awareness

6. Pharmacodynamic Overview of Molnupiravir

6.1. Mechanism of Action

6.2. Absorption

6.3. Volume of Distribution

6.4. Protein Binding

6.5. Metabolism

6.6. Route of Elimination

6.7. Half Life

6.8. Clearance

7. Clinical Trials

7.1. Ongoing Clinical Trials

7.2. Completed Clinical Trials

7.3. Terminated Clinical Trials

7.4. Clinical Trial Analysis

8. Patent Analysis

8.1. Patent Granted (2017-2021)

8.2. Patent Applications Filed

9. Global Molnupiravir Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value & Volume

9.2. Market Share & Forecast

9.2.1. By Application (Influenza, Ebola, COVID-19, Others)

9.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

9.2.3. By Company (2021)

9.2.4. By Region

9.3. Pricing Analysis

9.4. Product Market Map

10. North America Molnupiravir Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value & Volume

10.2. Market Share & Forecast

10.2.1. By Application

10.2.2. By Distribution Channel

10.2.3. By Country

10.3. Pricing Analysis

10.4. North America: Country Analysis

10.4.1. United States Molnupiravir Market Outlook

10.4.1.1. Market Size & Forecast

10.4.1.1.1. By Value & Volume

10.4.1.2. Market Share & Forecast

10.4.1.2.1. By Application

10.4.1.2.2. By Distribution Channel

10.4.2. Mexico Molnupiravir Market Outlook

10.4.2.1. Market Size & Forecast

10.4.2.1.1. By Value & Volume

10.4.2.2. Market Share & Forecast

10.4.2.2.1. By Application

10.4.2.2.2. By Distribution Channel

10.4.3. Canada Molnupiravir Market Outlook

10.4.3.1. Market Size & Forecast

10.4.3.1.1. By Value & Volume

10.4.3.2. Market Share & Forecast

10.4.3.2.1. By Application

10.4.3.2.2. By Distribution Channel

11. Europe Molnupiravir Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value & Volume

11.2. Market Share & Forecast

11.2.1. By Application

11.2.2. By Distribution Channel

11.2.3. By Country

11.3. Pricing Analysis

11.4. Europe: Country Analysis

11.4.1. France Molnupiravir Market Outlook

11.4.1.1. Market Size & Forecast

11.4.1.1.1. By Value & Volume

11.4.1.2. Market Share & Forecast

11.4.1.2.1. By Application

11.4.1.2.2. By Distribution Channel

11.4.2. Germany Molnupiravir Market Outlook

11.4.2.1. Market Size & Forecast

11.4.2.1.1. By Value & Volume

11.4.2.2. Market Share & Forecast

11.4.2.2.1. By Application

11.4.2.2.2. By Distribution Channel

11.4.3. United Kingdom Molnupiravir Market Outlook

11.4.3.1. Market Size & Forecast

11.4.3.1.1. By Value & Volume

11.4.3.2. Market Share & Forecast

11.4.3.2.1. By Application

11.4.3.2.2. By Distribution Channel

11.4.4. Italy Molnupiravir Market Outlook

11.4.4.1. Market Size & Forecast

11.4.4.1.1. By Value & Volume

11.4.4.2. Market Share & Forecast

11.4.4.2.1. By Application

11.4.4.2.2. By Distribution Channel

11.4.5. Spain Molnupiravir Market Outlook

11.4.5.1. Market Size & Forecast

11.4.5.1.1. By Value & Volume

11.4.5.2. Market Share & Forecast

11.4.5.2.1. By Application

11.4.5.2.2. By Distribution Channel

11.4.6. Denmark Molnupiravir Market Outlook

11.4.6.1. Market Size & Forecast

11.4.6.1.1. By Value & Volume

11.4.6.2. Market Share & Forecast

11.4.6.2.1. By Application

11.4.6.2.2. By Distribution Channel

12. Asia-Pacific Molnupiravir Market Outlook

12.1. Market Size & Forecast

12.1.1. By Value & Volume

12.2. Market Share & Forecast

12.2.1. By Application

12.2.2. By Distribution Channel

12.2.3. By Country

12.3. Pricing Analysis

12.4. Asia-Pacific: Country Analysis

12.4.1. China Molnupiravir Market Outlook

12.4.1.1. Market Size & Forecast

12.4.1.1.1. By Value & Volume

12.4.1.2. Market Share & Forecast

12.4.1.2.1. By Application

12.4.1.2.2. By Distribution Channel

12.4.2. India Molnupiravir Market Outlook

12.4.2.1. Market Size & Forecast

12.4.2.1.1. By Value & Volume

12.4.2.2. Market Share & Forecast

12.4.2.2.1. By Application

12.4.2.2.2. By Distribution Channel

12.4.3. South Korea Molnupiravir Market Outlook

12.4.3.1. Market Size & Forecast

12.4.3.1.1. By Value & Volume

12.4.3.2. Market Share & Forecast

12.4.3.2.1. By Application

12.4.3.2.2. By Distribution Channel

12.4.4. Japan Molnupiravir Market Outlook

12.4.4.1. Market Size & Forecast

12.4.4.1.1. By Value & Volume

12.4.4.2. Market Share & Forecast

12.4.4.2.1. By Application

12.4.4.2.2. By Distribution Channel

12.4.5. Australia Molnupiravir Market Outlook

12.4.5.1. Market Size & Forecast

12.4.5.1.1. By Value & Volume

12.4.5.2. Market Share & Forecast

12.4.5.2.1. By Application

12.4.5.2.2. By Distribution Channel

12.4.6. Vietnam Molnupiravir Market Outlook

12.4.6.1. Market Size & Forecast

12.4.6.1.1. By Value & Volume

12.4.6.2. Market Share & Forecast

12.4.6.2.1. By Application

12.4.6.2.2. By Distribution Channel

12.4.7. Philippines Molnupiravir Market Outlook

12.4.7.1. Market Size & Forecast

12.4.7.1.1. By Value & Volume

12.4.7.2. Market Share & Forecast

12.4.7.2.1. By Application

12.4.7.2.2. By Distribution Channel

12.4.8. Indonesia Molnupiravir Market Outlook

12.4.8.1. Market Size & Forecast

12.4.8.1.1. By Value & Volume

12.4.8.2. Market Share & Forecast

12.4.8.2.1. By Application

12.4.8.2.2. By Distribution Channel

12.4.9. Malaysia Molnupiravir Market Outlook

12.4.9.1. Market Size & Forecast

12.4.9.1.1. By Value & Volume

12.4.9.2. Market Share & Forecast

12.4.9.2.1. By Application

12.4.9.2.2. By Distribution Channel

13. South America Molnupiravir Market Outlook

13.1. Market Size & Forecast

13.1.1. By Value & Volume

13.2. Market Share & Forecast

13.2.1. By Application

13.2.2. By Distribution Channel

13.2.3. By Country

13.3. Pricing Analysis

13.4. South America: Country Analysis

13.4.1. Brazil Molnupiravir Market Outlook

13.4.1.1. Market Size & Forecast

13.4.1.1.1. By Value & Volume

13.4.1.2. Market Share & Forecast

13.4.1.2.1. By Application

13.4.1.2.2. By Distribution Channel

13.4.2. Argentina Molnupiravir Market Outlook

13.4.2.1. Market Size & Forecast

13.4.2.1.1. By Value & Volume

13.4.2.2. Market Share & Forecast

13.4.2.2.1. By Application

13.4.2.2.2. By Distribution Channel

13.4.3. Colombia Molnupiravir Market Outlook

13.4.3.1. Market Size & Forecast

13.4.3.1.1. By Value & Volume

13.4.3.2. Market Share & Forecast

13.4.3.2.1. By Application

13.4.3.2.2. By Distribution Channel

14. Middle East and Africa Molnupiravir Market Outlook

14.1. Market Size & Forecast

14.1.1. By Value & Volume

14.2. Market Share & Forecast

14.2.1. By Application

14.2.2. By Distribution Channel

14.2.3. By Country

14.3. Pricing Analysis

14.4. MEA: Country Analysis

14.4.1. South Africa Molnupiravir Market Outlook

14.4.1.1. Market Size & Forecast

14.4.1.1.1. By Value & Volume

14.4.1.2. Market Share & Forecast

14.4.1.2.1. By Application

14.4.1.2.2. By Distribution Channel

14.4.2. Saudi Arabia Molnupiravir Market Outlook

14.4.2.1. Market Size & Forecast

14.4.2.1.1. By Value & Volume

14.4.2.2. Market Share & Forecast

14.4.2.2.1. By Application

14.4.2.2.2. By Distribution Channel

14.4.3. UAE Molnupiravir Market Outlook

14.4.3.1. Market Size & Forecast

14.4.3.1.1. By Value & Volume

14.4.3.2. Market Share & Forecast

14.4.3.2.1. By Application

14.4.3.2.2. By Distribution Channel

14.4.4. Kenya Molnupiravir Market Outlook

14.4.4.1. Market Size & Forecast

14.4.4.1.1. By Value & Volume

14.4.4.2. Market Share & Forecast

14.4.4.2.1. By Application

14.4.4.2.2. By Distribution Channel

15. Market Dynamics

15.1. Drivers

15.2. Challenges

16. Market Trends & Developments

17. Competitive Landscape

17.1. Company Profiles

17.1.1. Company Details

17.1.2. Financials (As reported)

17.1.3. Key Market Focus and Geographical Presence

17.1.4. Pricing of Target Products

17.1.5. Market positioning

17.2. Merck Sharp & Dohme Corp.

17.3. Everest Organics Limited

17.4. Optimus Drugs Pvt Ltd.

17.5. Dr. Reddy’s Laboratories Ltd

17.6. Cipla Limited

17.7. Mylan N.V.

17.8. Emcure Pharmaceuticals Ltd.

17.9. Sun Pharmaceutical Industries Limited

17.10. Hetero Drugs Ltd.

17.11. Torrent Pharmaceuticals Ltd.

18. Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

What major factors drive Global Molnupiravir Market growth?

Global Molnupiravir market may grow with impressive CAGR during the forecast period, 2023-2027, on account of increasing instances of COVID-19, coupled with surging demand for effective drugs against coronavirus.

Which region dominates the Global Molnupiravir Market analysis?

The global Molnupiravir market is segmented into North America region, South America region, Asia Pacific region, European region, and Middle East & Africa region for the regional analysis of the market. North America region is anticipated to dominate the market analysis in the upcoming five years on the account of expanding pharmaceutical industry and economies like the United States authorizing the use of drug on the population.

Which companies dominate the Global Molnupiravir Market?

Merck Sharp & Dohme Corp., Everest Organics Limited, Optimus Drugs Pvt Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Mylan N.V., Emcure Pharmaceuticals Ltd., Sun Pharmaceutical Industries Limited, Hetero Drugs Ltd., Torrent Pharmaceuticals Ltd., among others are some of the leading companies dedicated toward providing related products and services of Molnupiravir and support the future growth of the global Molnupiravir market in the upcoming five years.

What strategic recommendations may the new market players follow in future?

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.